Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
October 21, 2014, 04:48:24 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 642846
  • Total Topics: 48904
  • Online Today: 213
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 1
Guests: 191
Total: 192

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: HIV Treatment News: As soon as possible  (Read 1336 times)

0 Members and 1 Guest are viewing this topic.

Offline Mishma

  • Member
  • Posts: 190
    • Marquis de Vauban
HIV Treatment News: As soon as possible
« on: July 23, 2012, 06:15:55 PM »
HIV Treatment Should Begin as Early as Possible
Martha Kerr
July 22, 2012 (Washington, DC) — New recommendations for antiretroviral therapy (ART), issued here on opening day of AIDS 2012: XIX International AIDS Conference, say that ART should be offered to all adult patients who are HIV-positive as soon as possible, regardless of CD4 cell count.

The earlier it is offered, the better the outcome, Melanie A. Thompson, MD, of the AIDS Research Consortium of Atlanta, Georgia, told meeting delegates. Dr. Thompson headed the 2012 Recommendations of the International Antiviral Society–USA Panel (IAS-USA). Their conclusions are in a special edition of the Journal of the American Medical Association, to be published July 25.

"Since the first antiretroviral drug was approved 25 years ago, improvements in the potency, tolerability, simplicity, and availability of ART have resulted in dramatically reduced numbers of opportunistic diseases and deaths where ART is available," she said.

Dr. Thompson and colleagues reviewed the literature on treatment outcomes over the past 2 years to assess treatment guidelines.

Foremost, she said, is that ART treatment is recommended for all adults infected with HIV. The investigators found "no CD4 cell count threshold at which starting therapy is contraindicated, but the strength of the recommendation and the quality of the evidence supporting initiation of therapy increase as the CD4 cell count decreases and when certain concurrent conditions are present."

As the authors write in their recommendations, "The aim of therapy continues to be maximal, lifelong, and continuous suppression of HIV replication to prevent emergence of resistance, facilitate optimal immune recovery, and improve health."

"HIV monitoring should be part of a routine examination, but it needs to be individualized," Dr. Thompson told Medscape Medical News. "It is part of what we do."

Adherence to treatment is a problem, "and is something we need to do," she added. Tracking and monitoring patients is now becoming an issue, because many patients drop out of treatment and are lost to follow-up.

Treatment should begin even in the presence of opportunistic infections, Dr. Thompson asserted. "In earlier days, we thought it was better to delay ART until opportunistic infections were under control. Now we know that is not a good idea.

"We realize these guidelines are aspirational, and should guide treatment" going forward, she acknowledged. "This is going to be a problem for insurance companies...but I reject the idea that there is not enough money. We have to prioritize. This is the right thing to do. This meeting is about advocacy and doing the right thing," Dr. Thompson declared.

The guidelines were supported by the IAS-USA. Dr. Thompson and colleagues have disclosed various conflicts of interest. A full list is available on the JAMA Web site .

AIDS 2012: XIX International AIDS Conference.Presented at a press briefing July 22, 2012.

JAMA. 2012;308:387-402. Full text

Medscape Medical News © 2012 WebMD, LLC
Send comments and news tips to news@medscape.net.
2016 CD4 25% UD (less than 20). 27+ years positive. Isentress, Truvada, Acyclovir, Clonazepam, Zolpidem, Bupropion, Lisinopril, Pravastatin, Quetiapine, Doxcycline, Testosterone, Suatriptan/Naproxen, Restasis, Dorzolamide, Latanoprost, Asprin, lortab, Levothyroxine, Fioricet, Restasis, Triamclinolone, Nitrostat.

Offline leatherman

  • Member
  • Posts: 6,272
  • Google and HIV meds are Your Friends
Re: HIV Treatment News: As soon as possible
« Reply #1 on: July 23, 2012, 06:38:13 PM »
this issue is also under discussion in "Treat all HIV infections, Global Panel", though that thread was based off an NBC article.
leatherman (aka mIkIE)


chart from 1992-2013; updated 2/09/13  Reyataz/Norvir/Truvada

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.